Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10084650rdf:typepubmed:Citationlld:pubmed
pubmed-article:10084650lifeskim:mentionsumls-concept:C0138741lld:lifeskim
pubmed-article:10084650lifeskim:mentionsumls-concept:C0007112lld:lifeskim
pubmed-article:10084650lifeskim:mentionsumls-concept:C0205101lld:lifeskim
pubmed-article:10084650lifeskim:mentionsumls-concept:C0851346lld:lifeskim
pubmed-article:10084650lifeskim:mentionsumls-concept:C0456603lld:lifeskim
pubmed-article:10084650lifeskim:mentionsumls-concept:C2347880lld:lifeskim
pubmed-article:10084650lifeskim:mentionsumls-concept:C0439231lld:lifeskim
pubmed-article:10084650pubmed:issue2lld:pubmed
pubmed-article:10084650pubmed:dateCreated1999-3-24lld:pubmed
pubmed-article:10084650pubmed:abstractTextThe purpose of this study was to evaluate free-to-total prostate-specific antigen (PSA) ratios after definitive external beam radiation therapy for men with adenocarcinoma of the prostate (CaP).lld:pubmed
pubmed-article:10084650pubmed:languageenglld:pubmed
pubmed-article:10084650pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10084650pubmed:citationSubsetIMlld:pubmed
pubmed-article:10084650pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10084650pubmed:statusMEDLINElld:pubmed
pubmed-article:10084650pubmed:monthFeblld:pubmed
pubmed-article:10084650pubmed:issn0022-4790lld:pubmed
pubmed-article:10084650pubmed:authorpubmed-author:WardJ FJFlld:pubmed
pubmed-article:10084650pubmed:authorpubmed-author:Gu?uV JVJlld:pubmed
pubmed-article:10084650pubmed:authorpubmed-author:JohnstoneP...lld:pubmed
pubmed-article:10084650pubmed:issnTypePrintlld:pubmed
pubmed-article:10084650pubmed:volume70lld:pubmed
pubmed-article:10084650pubmed:ownerNLMlld:pubmed
pubmed-article:10084650pubmed:authorsCompleteYlld:pubmed
pubmed-article:10084650pubmed:pagination91-4lld:pubmed
pubmed-article:10084650pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10084650pubmed:meshHeadingpubmed-meshheading:10084650...lld:pubmed
pubmed-article:10084650pubmed:meshHeadingpubmed-meshheading:10084650...lld:pubmed
pubmed-article:10084650pubmed:meshHeadingpubmed-meshheading:10084650...lld:pubmed
pubmed-article:10084650pubmed:meshHeadingpubmed-meshheading:10084650...lld:pubmed
pubmed-article:10084650pubmed:meshHeadingpubmed-meshheading:10084650...lld:pubmed
pubmed-article:10084650pubmed:meshHeadingpubmed-meshheading:10084650...lld:pubmed
pubmed-article:10084650pubmed:meshHeadingpubmed-meshheading:10084650...lld:pubmed
pubmed-article:10084650pubmed:year1999lld:pubmed
pubmed-article:10084650pubmed:articleTitleFree-to-total prostate-specific antigen ratios 18-24 months following external beam radiation for adenocarcinoma of the prostate.lld:pubmed
pubmed-article:10084650pubmed:affiliationDepartment of Urology, Naval Medical Center, San Diego, California 92134-5000, USA. jfward@snd10.med.navy.millld:pubmed
pubmed-article:10084650pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10084650pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10084650pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:10084650pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed